XML 61 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Stock Option Awards and Restricted Stock Grants (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, granted $ 4.16 $ 2.03
Weighted average contractual terms, exercisable 7 years 6 months  
Share-Based Payment Arrangement, Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 441,425  
Weighted average exercise price, beginning balance $ 38.49  
Options outstanding, granted 224,276  
Weighted average exercise price, granted $ 4.60  
Options outstanding, ending balance 665,701  
Weighted average exercise price, ending balance $ 27.07  
Weighted average contractual terms 8 years  
Options outstanding, aggregate intrinsic value $ 103,167  
Options outstanding, exercisable 419,559  
Weighted average exercise price, exercisable $ 33.22  
Options outstanding, aggregate intrinsic value, exercisable $ 34,304  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Non-vested stock awards, beginning balance 1,481  
Weighted average grant date fair value, beginning balance $ 12.36  
Non-vested stock awards, granted 400  
Weighted average grant date fair value, granted $ 4.60  
Non-vested stock awards, ending balance 1,881  
Weighted average grant date fair value, ending balance $ 10.71  
Non-vested stock awards, aggregate intrinsic value $ 20,145